Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

58.01 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
48 49 Next >
CVS Health Pilots Remote System To Fill Prescriptions: Report
CVS Health Corp (NYSE: CVS) is piloting a system, enabling pharmacists to process prescriptions in part remotely, in order to tackle the shortage of pharmacists. 
Via Benzinga
Why Cano Health's Shares Dropped 46.9% in November
Lowered guidance and big third-quarter losses worried investors. 
Via The Motley Fool
2 High-Yielding Grocery REITs Offer Best 'Bang For Your Buck' As A Global Recession Looms
Although the all-items index increased 7.7% for the twelve months ending October, this was the smallest 12-month increase since the period ending January 2022. Meanwhile, food inflation increased by... 
Via Benzinga
Why Healthcare Could Be a Make-or-Break Strategy for Walgreens
Is the company's expansion into healthcare a good reason to buy the stock? 
Via The Motley Fool
7 Bullseye Stock Picks for Your 2023 Must-Buy List
Leave the bearishness of 2022 in the rear-view mirror with these seven stock picks for 2023 that offer massive potential at these multiples. 
Via InvestorPlace
10 Analysts Have This to Say About CVS Health
Via Benzinga
Where CVS Health Stands With Analysts
Via Benzinga
Here's How Much You Would Have Made Owning CVS Health Stock In The Last 20 Years
Via Benzinga
CVS Stock Investors Can Breathe a Sigh of Relief
CVS stock got a quick boost after the company released some positive news - not just on the earnings front, but also with a legal resolution. 
Via InvestorPlace
It's Cyber Monday: These 2 Mall REITs Are Offering Investors Better Than Average Yields
Using data gathered from Sept. 30, 2019, SP Global reported that over a 10-year period, real estate investment trusts (REITs) dealing with the retail industry had an average annual return of 10.1%. 
Via Benzinga
Here's Why This Dividend Stock Is a Buy
The pharmacy retailer and health insurer provides indispensable goods and services to consumers. 
Via The Motley Fool
Investors Show Optimism For Retail REITs On Black Friday
Retail stocks had mixed results during market hours Friday as early reports suggested the shopping holiday was off to a slower-than-normal start. 
Via Benzinga
3 Things Making CVS Stock More Attractive Right Now
The health services giant's plans to buy $10 billion worth of CVS stock could help to boost returns for shares going forward. 
Via InvestorPlace
Expert Ratings for CVS Health
CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Is CVS Health Stock a Buy After the Q3 Earnings Beat?
There's good news and bad news for the healthcare giant. 
Via The Motley Fool
Salesforce To $240? Plus RBC Capital Boosts PT For Autodesk
Jefferies cut the price target on Salesforce, Inc. (NYSE: CRM) from $250 to $240. Jefferies analyst Brent Thill maintained the stock with a Buy rating. Salesforce shares fell 1.2% to trade at $146.20... 
Via Benzinga
JPMorgan Poaches Walmart's Health And Fitness Official For Its Health Venture
Via Benzinga
5 Signs You May Have a Recession-Proof Stock
There's no such thing as a perfectly safe stock, but here are some ways to assess recession readiness. 
Via The Motley Fool
Why Shares of Cano Health Plummeted 29.5% This Week
The value-based healthcare insurer is seen as a potential buyout candidate. 
Via The Motley Fool
NextEra Energy, General Motors, CVS Health And This FCF Play Feature On CNBC's 'Final Trades'
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose General Motors Company (NYSE: GM) ahead of itsanalyst day webcast. 
Via Benzinga
Why Rite Aid Stock Jumped by 15.6% Tuesday
The pharmacy chain operator's shares hit their highest level in more than a month. 
Via The Motley Fool
Here's What Wall St. Experts Are Saying About Walmart Ahead Of Earnings
Walmart to report Q3 earnings before the market opens Tuesday. 
Via Talk Markets
2 Stocks I'd Buy Right Now Without Hesitation
One's a growth stock and the other pays a dividend but both of these healthcare businesses have what it takes to reliably outperform. 
Via The Motley Fool
3 Stocks That May Be Kicked Out of the Dow Jones Industrial Average (and the 3 Stocks That Could Replace Them)
There have been more than 50 changes to the Dow since 1896. Removing these three established companies could be next on the docket. 
Via The Motley Fool
Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?
U.S. voters will spend the majority of Tuesday casting their ballots for the candidates they want to represent them in Congress, which consists of the House of Representatives and the Senate. 
Via Benzinga
Where CVS Health Stands With Analysts
Over the past 3 months, 8 analysts have published their opinion on CVS Health (NYSE:CVS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
3 Stocks to Avoid This Week
These investments seem pretty vulnerable right now. 
Via The Motley Fool
7 Stocks to Buy With Stacks of Free Cash Flow
Use the Portfolio Grader to find stocks to buy that have plenty of free cash flow and can easily afford to fund dividends or stock buybacks. 
Via InvestorPlace
This Senator Is Shorting Companies With A Bear ETF, He Also Purchased These 2 Dividend Paying Stocks
Senator Thomas Carper (D-DE) has made over 550 trades in the past three years, which are typically filed under his spouse, as reported by Capitol Trades. Carper is a member of the Senate Committee on... 
Via Benzinga
CVS Health's Return On Capital Employed Overview
Benzinga Pro data, CVS Health (NYSE:CVS) reported Q3 sales of $81.16 billion. Earnings fell to a loss of $3.41 billion, resulting in a 215.13% decrease from last quarter. 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.